Physician profile
Brian Arcement
NPI 1083682538
$1,776.33
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $734 · 2020: $167 · 2021: $314 · 2022: $400 · 2023: $145 · 2024: $16.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $657.45 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Cvrx, INC. | $303.18 | 2021-2023 | Barostim Neo System |
| Medtronic, INC. | $133.17 | 2022-2023 | Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.69 | 2019-2023 | Lifevest |
| Cardiovascular Systems INC. | $83.14 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.67 | 2019 | |
| Abbott Laboratories | $74.90 | 2019-2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $72.54 | 2020 | |
| Janssen Pharmaceuticals, INC | $52.54 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $51.41 | 2019 | |
| Kestra Medical Technology Services, INC. | $40.78 | 2023 | Assure Wcd |
| Chiesi USA, INC. | $35.57 | 2019-2021 | |
| Abiomed | $33.20 | 2019-2024 | Impella |
| Amgen INC. | $29.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.05 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Arcement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.